DCOS

Biomarker

1 paper1 finding

  • Humans1

Associations

1

Mild neurocognitive disorder

upin humans1

1 study
  1. DCOS predicts mild neurocognitive disorder in humans (AUC=0.87, 88% sensitivity, 69% specificity).

    “External validation confirmed robust performance with improved diagnostic accuracy (AUC=0.87), achieving 88% sensitivity and 69% specificity”

    Humansvalidation cohortn = 127

    Development and validation of the DCOS (Digitalised Combined Objective‐Subjective cognitive screening): A five‐minute neuropsychological test for mild neurocognitive disorder

    AAIC 2025 abstract23 Dec 2025

More on Mild neurocognitive disorder

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months